Case Report {#sec1_1}
===========

A 45-year-old woman was admitted to our hospital 9 days after the apparition of asthenia and progressive jaundice. She was working as a nutritionist in the Darfur region of western Sudan, had no personal or family history of liver disease and was not consuming illicit drugs or alcohol. She had received hepatitis A and B vaccines. The day prior to transfer in Geneva, she developed grade IV hepatitis E, was electively intubated and given intravenous mannitol. Computed tomography showed a grossly normal liver with patent hepatic veins and ascites. Diffuse cerebral edema was evident both at cranial computed tomography and MRI scans ([**fig.**]{.ul} [[**1**]{.ul}](#F1){ref-type="fig"}). Laboratory values were as follows: aspartate aminotransferase 436 IU/l (N: 1-42), alanine aminotransferase 1,813 IU/l (N: 9-42), total bilirubin 436 μmol/l (N: 7-25), alkaline phosphatase 107 IU/l (N: 30-125), ammonium 118 μmol/l (N: 11-35), creatinine 72 μmol/l (N: 35-88), phosphate 0.63 mmol/l (N: 0.8-1.5), prothrombin time 59 s, INR 6, and factor V 20%. Alpha fetoprotein level was 219 ng/ml (N: \<15). She tested negative for autoimmune, toxic and metabolic diseases as well as for hepatitis A, B, C, and HIV. However, high titers of anti-HEV antibodies (enzyme immunoassay Abbott HEV EIA) were detected in the serum. The levels of anti-HEV IgG and IgM were 3,000 (threshold level at 520) and 1,848 (threshold level at 420) optical densities, respectively. There was no evidence of infection. Thus, in the presence of acute liver failure (factor V \<30%) complicated by rapid neurological deterioration and brain edema on imaging studies, spontaneous survival was estimated below 10% according to Clichy\'s criteria \[[@B1]\], and the patient was listed for urgent liver transplantation while receiving standard supportive care but no hypothermia or liver support device. She remained stable during the two following days and progressively started to breathe spontaneously and to respond to painful stimuli. Figure [1](#F1){ref-type="fig"} illustrates the spontaneous progressive improvement in biological tests starting from day 2 of hospital admission. She was then delisted. On day 4, she was fully conscious and oriented. Brain edema had completely resolved on repeat cranial MRI. The neurological status was normal at hospital discharge on day 22.

Discussion {#sec1_2}
==========

Hepatitis E virus is a frequent cause of acute hepatitis in developing countries \[[@B2]\]. High mortality was initially described in pregnant women from endemic countries, but sporadic cases \[[@B3]\], sometimes fatal \[[@B4]\], have been described both in males and nonpregnant females from Western Europe. In acute liver failure, prognostic markers that dictate the need for urgent liver transplantation include the King\'s College and Clichy\'s criteria \[[@B1]\], and more recently the MELD \[[@B5]\]. Our patient fulfilled all these criteria. Although useful, these tools are not 100% accurate in predicting spontaneous outcome. Factors that may positively influence the course of the hepatitis include viral cause, hyperacute presentation, elevated AFP and no infection, while the presence of profound hepatitis E complicated by cerebral edema is clearly associated with a poor prognosis without urgent liver transplantation.

Whether the particular evolution of our case with fulminant hepatic failure relates to host factors or to the causative agent remains unclear. Neurological symptoms associated with hepatitis E include meningoencephalitis with seizures \[[@B6]\] and spontaneously reversible grade III hepatitis E in the setting of both acute liver and renal failure \[[@B7]\]. The combined action of acute hepatitis and associated hyperammonemia-induced increased permeability of the blood brain barrier may increase the risk of hepatitis E and brain edema \[[@B8]\].

Although the present case underlines the limitations of prognostic scoring in this life-threatening condition, the treatment of patients with fulminant hepatic failure remains urgent liver transplantation \[[@B9]\].
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